Drugplain

Sugar Hard Maple Pollen .05 g/mL

Acer saccharum · SOLUTION · Greer Laboratories, Inc.

No Recall History
Plain English

Sugar Hard Maple Pollen is a solution containing acer saccharum at .05 g/mL, taken intradermal. Manufactured by Greer Laboratories, Inc..

Key Facts

Brand Name
Sugar Hard Maple Pollen
Generic Name
Acer saccharum
NDC Code (Product)
22840-5441
Manufacturer
Greer Laboratories, Inc.
Strength
.05 g/mL
Dosage Form
SOLUTION
Route
INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
Marketing Status
Application #
BLA101833
Marketing Start
09/15/1981

Recall History

No Recall History

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Use: For contitutional treatments based on homeopathic and anthroposophic indications or as directed by your physician.

Dosage & Administration

Directions for Use: Place drops under tongue for 30 seconds. Adults3-5 drops 3 times a day. Children 2-12 years--3-5 drops 3 times a day. Under 2 years, consult your doctor. Use until symptoms are relieved or as directed by your health care provider.

Warnings

Warnings: Consult your health care provider if symptoms persist more than 5 days or worsen.

Frequently Asked Questions

What is Sugar Hard Maple Pollen used for?

Sugar Hard Maple Pollen contains Acer saccharum. It is a solution taken intradermal. Consult your doctor for specific uses.

Is Sugar Hard Maple Pollen a controlled substance?

Sugar Hard Maple Pollen is not classified as a controlled substance by the DEA.

What is the generic name for Sugar Hard Maple Pollen?

The generic name for Sugar Hard Maple Pollen is Acer saccharum. There are 8 other brand versions of Acer saccharum.

What is the NDC code for Sugar Hard Maple Pollen .05 g/mL?

The NDC (National Drug Code) for Sugar Hard Maple Pollen .05 g/mL is 22840-5441, listed by Greer Laboratories, Inc..

Product NDC

22840-5441

Package NDC

22840-5441-2

Other Acer Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)